Breaking News Instant updates and real-time market news.

MMM

3M

$171.14

-0.19 (-0.11%)

, GOOG

Alphabet

$785.94

10.86 (1.40%)

09:03
10/11/16
10/11
09:03
10/11/16
09:03

3M, Alphabet unit to develop new population health measurement technology

3M Health Information Systems, a business of 3M (MMM), and Verily Life Sciences, an Alphabet (GOOG) company, announced that they have entered into a strategic agreement to develop new population health measurement technology for managing clinical and financial performance. The joint technology platform will be designed to analyze quality performance data across healthcare delivery systems and patient populations, and deliver meaningful information that can be used to promote real and sustainable improvements in healthcare quality and cost. The 3M and Verily platform will be designed to include quality measures that assess complications, readmissions and mortality, and cost measures like length of stay and specific service line costs. It will evaluate multiple performance measures across departments, procedures and practitioners, including downstream providers such as specialists, home health and transitional care facilities.

MMM

3M

$171.14

-0.19 (-0.11%)

GOOG

Alphabet

$785.94

10.86 (1.40%)

GOOGL

Alphabet Class A

$814.17

13.46 (1.68%)

  • 11

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 10

    Nov

  • 17

    Nov

  • 13

    Dec

  • 15

    Jan

MMM 3M
$171.14

-0.19 (-0.11%)

03/15/16
BOFA
03/15/16
NO CHANGE
BOFA
Danaher added to US 1 List, 3M and Thermo Fisher removed at BofA/Merrill
03/30/16
UBSW
03/30/16
NO CHANGE
Target $190
UBSW
Buy
3M price target raised to $190 from $170 at UBS
UBS raised its price target on 3M to $190 from $170 citing the company's product innovation and management's growth guidance. The firm also expects margin gains and improved cyclical industrial trends. UBS reiterated its Buy rating on 3M shares.
04/12/16
JEFF
04/12/16
NO CHANGE
Target $187
JEFF
Buy
3M price target raised to $187 from $175 at Jefferies
Jefferies analyst Laurence Alexander raised his price target for 3M to $187 saying indicators suggest a more favorable growth environment for the company's short-cycle businesses in Q2 and possibly even Q3. The analyst, however, cautions that the valuations are starting to look stretched at current levels. He keeps a Buy rating on 3M.
09/07/16
FBCO
09/07/16
NO CHANGE
Target $195
FBCO
Outperform
3M price target raised to $195 from $186 at Credit Suisse
Credits Suisse analysts led by Julian Mitchell raised 3M's price target to $195 from $186 following last week's investor meetings with CFO Nick Gangestad in Canada last week. The analyst came away with increased conviction that the Business Transformation and manufacturing footprint efforts could drive higher earnings accretion quicker than consensus assumes. Mitchell has an Outperform rating on 3M shares.
GOOG Alphabet
$785.94

10.86 (1.40%)

09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
SBSH
10/06/16
NO CHANGE
Target $89
SBSH
Buy
Citi says Salesforce buying Twitter 'nearly impossible' above $28/share
Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.
GOOGL Alphabet Class A
$814.17

13.46 (1.68%)

09/30/16
RBCM
09/30/16
NO CHANGE
RBCM
Street underestimating Google growth outlook, says RBC Capital
RBC Capital analyst Mark Mahaney expects Google to end 2016 with "up to 20% growth," versus the Street's outlook of mid teen percentage level growth. Mahaney says that Google's growth should be boosted by "ongoing Search innovations, rising Mobile CPCs, and the growing impact of YouTube, Play & Cloud." He thinks that YouTube's revenue is growing at a 30%-40% clip. Mahaney raised his price target on the stock to $1,025 from $1,000 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

CSGP

CoStar Group

$319.06

-2.96 (-0.92%)

08:14
01/17/18
01/17
08:14
01/17/18
08:14
Hot Stocks
CoStar Group partners with Kansas City Regional Association of Realtors »

CoStar Group announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SQM

SQM

$58.59

-4.14 (-6.60%)

08:12
01/17/18
01/17
08:12
01/17/18
08:12
Upgrade
SQM rating change  »

SQM upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$18.51

-0.19 (-1.02%)

08:12
01/17/18
01/17
08:12
01/17/18
08:12
Periodicals
Deutsche Bank to shift fewer London jobs than expected, Reuters reports »

Deutsche Bank expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

F

Ford

$13.10

-0.13 (-0.98%)

08:11
01/17/18
01/17
08:11
01/17/18
08:11
Technical Analysis
Technical Take: Ford down following update, FY17 and FY18 EPS view »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

VBIV

VBI Vaccines

$4.36

-0.1 (-2.24%)

08:10
01/17/18
01/17
08:10
01/17/18
08:10
Hot Stocks
VBI Vaccines doses first patient in Phase 1/2a clinical study of VBI-1901 »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DERM

Dermira

$26.96

-0.48 (-1.75%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Recommendations
Dermira analyst commentary  »

Dermira price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

, IXYS

IXYS

$23.05

-1.55 (-6.30%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Hot Stocks
Littelfuse completes acquisition of IXYS »

Littelfuse (LFUS)…

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

IXYS

IXYS

$23.05

-1.55 (-6.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

DKS

Dick's Sporting

$32.33

-1 (-3.00%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Technical Analysis
Technical Take: Dick's Sporting higher in pre-market, analyst action »

At time of writing, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Conference/Events
Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

MGP

MGM Growth

$29.50

0.96 (3.36%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
VICI Properties rejects unsolicited proposal from MGM Growth »

VICI Properties confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.31

-0.07 (-2.94%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
Pareteum awarded $3M contract to add mobility to South American data provider »

Pareteum has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$38.94

-0.23 (-0.59%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Cornerstone OnDemand to separate chairman and CEO roles »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 13

    Mar

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

, AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Overwatch League opening week draws more than 10M viewers »

The Overwatch League…

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

NTES

NetEase

$322.08

-6.75 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

KNX

Knight-Swift

$44.63

-0.37 (-0.82%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Conference/Events
Knight-Swift management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 30

    Jan

MPLX

MPLX

$38.28

-0.5 (-1.29%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
MPLX announces joint open season for Cushing-to-Patoka pipeline expansion »

MPLX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$232.90

4.26 (1.86%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$167.54

-1.76 (-1.04%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
Deere analyst commentary  »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

RIOT

Riot Blockchain

$18.28

-3.6 (-16.45%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Hot Stocks
Riot Blockchain's Tess Pay signs agreement for Cresval Capital transaction »

Riot Blockchain's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

WAFD

Washington Federal

$35.60

-0.05 (-0.14%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Washington Federal reports Q4 EPS 59c, consensus 51c »

Return on equity for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Ichor Holdings sees Q1 revenue $240M-$250M, consensus $208.35M »

For 1Q18, Ichor expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OBE

Obsidian Energy

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Hot Stocks
FrontFour Capital voices concerns regarding Obsidian Energy »

FrontFour Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$54.90

0.07 (0.13%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Downgrade
HSBC rating change  »

HSBC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Earnings
Ichor Holdings sees Q4 revenue $183M, consensus $181.17M »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

RGC

Regal Entertainment

$22.90

-0.07 (-0.30%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Downgrade
Regal Entertainment rating change  »

Regal Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.55 (-2.93%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Hot Stocks
GE Transportation signs locomotive, service agreements valued at over $900M »

GE Transportation signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.